Matinas BioPharma Holdings, Inc.
MTNB
$0.18
$0.000.93%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 761.00K | 2.40M | 4.00M | 5.44M | 6.53M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 332.00K | 367.00K | 26.00K | 168.00K | 693.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K |
| Total Current Assets | 1.14M | 2.82M | 4.08M | 5.65M | 7.27M |
|
|
|||||
| Total Current Assets | 1.14M | 2.82M | 4.08M | 5.65M | 7.27M |
| Net Property, Plant & Equipment | 9.00K | 599.00K | 673.00K | 1.51M | 1.63M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.26M | 2.46M | 2.46M | 2.53M | 2.53M |
| Total Assets | 3.41M | 5.87M | 7.21M | 9.70M | 11.42M |
|
|
|||||
| Total Accounts Payable | 845.00K | 712.00K | 315.00K | 80.00K | 167.00K |
| Total Accrued Expenses | 504.00K | 694.00K | 452.00K | 564.00K | 795.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.00K | 720.00K | 696.00K | 851.00K | 822.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.35M | 2.13M | 1.46M | 1.50M | 1.78M |
|
|
|||||
| Total Current Liabilities | 1.35M | 2.13M | 1.46M | 1.50M | 1.78M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.00K | 469.00K | 658.00K | 1.48M | 1.71M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 257.00K | 257.00K | 257.00K | 257.00K | 257.00K |
| Total Liabilities | 1.61M | 2.85M | 2.38M | 3.24M | 3.75M |
|
|
|||||
| Common Stock & APIC | 215.83M | 215.73M | 215.62M | 215.34M | 214.40M |
| Retained Earnings | -214.03M | -212.71M | -210.79M | -208.88M | -206.73M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.80M | 3.02M | 4.83M | 6.46M | 7.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.80M | 3.02M | 4.83M | 6.46M | 7.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.80M | 3.02M | 4.83M | 6.46M | 7.68M |
|
|
|||||